Surfactant functionalization induces robust, differential adhesion of tumor cells and blood cells to charged nanotube-coated biomaterials under flow

Biomaterials

Volumn 56, Issue , 2015, Pages 179-186

  Mitchell, Michael J ^a,b   Castellanos, Carlos A ^a   King, Michael R ^a  

^a School of Operations Research and Industrial Engineering   (United States)

^b Massachusetts Institute of Technology   (United States)

Author keywords

Biomaterials; Circulating tumor cell; Halloysite; Leukocyte; Metastasis; Surfactant

Indexed keywords

ADHESION; BIOLOGICAL MATERIALS; BIOMATERIALS; BLOOD; CELL ADHESION; CYTOLOGY; DIAGNOSIS; DISEASES; ENDOTHELIAL CELLS; KAOLINITE; NANOTUBES; PATHOLOGY; SURFACE ACTIVE AGENTS; TUMORS; YARN;

BIOMATERIAL SURFACES; CIRCULATING TUMOR CELLS; FUNCTIONALIZED NANOTUBES; HALLOYSITE; LEUKOCYTE; MEDIATED INTERACTION; METASTASIS; STRAIGHTFORWARD TECHNIQUES;

CELLS;

ALKANE DERIVATIVE; ANIONIC SURFACTANT; BIOLOGICAL MARKER; BIOMATERIAL; CATIONIC SURFACTANT; CELL ADHESION MOLECULE; DODECYLTRIMETHYLAMMONIUM BROMIDE; HALLOYSITE NANOTUBE; NANOTUBE; PROTEIN; SODIUM DODECANOATE; SURFACTANT; UNCLASSIFIED DRUG; ALUMINUM SILICATE; CLAY; DECYLTRIMETHYLAMMONIUM; LIGAND; QUATERNARY AMMONIUM DERIVATIVE; SELECTIN;

ARTICLE; BLOOD CELL; CELL ADHESION; CELL FUNCTION; CELL GROWTH; CELL SURFACE; CIRCULATING TUMOR CELL; CONTROLLED STUDY; FLOW RATE; HUMAN; HUMAN CELL; LEUKOCYTE; LEUKOCYTE ADHERENCE; NANOENCAPSULATION; NANOFABRICATION; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL LINE; CELL SEPARATION; CHEMISTRY; CYTOLOGY; MCF-7 CELL LINE; METABOLISM; METASTASIS; PATHOLOGY; PROGNOSIS; TUMOR EMBOLISM;

ALUMINUM SILICATES; BIOCOMPATIBLE MATERIALS; BIOMARKERS; BLOOD CELLS; CELL ADHESION; CELL LINE, TUMOR; CELL SEPARATION; HUMANS; LEUKOCYTES; LIGANDS; MCF-7 CELLS; NANOTUBES; NEOPLASM METASTASIS; NEOPLASTIC CELLS, CIRCULATING; NEUTROPHILS; PROGNOSIS; QUATERNARY AMMONIUM COMPOUNDS; SELECTINS; SURFACE-ACTIVE AGENTS;

EID: 84928401726     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.03.045     Document Type: Article

References (56)

1. Chaffer C.L., Weinberg R.A. Aperspective on cancer cell metastasis. Science 2011, 331:1559-1564.
2. Chang Y.S., di Tomaso E., McDonald D.M., Jones R., Jain R.K., Munn L.L. Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. Proc Natl Acad Sci U S A 2000, 97:14608-14613.
3. Butler T.P., Gullino P.M. Quantitation of cell shedding into efferent blood of mammary adenocarcinoma. Cancer Res 1975, 35:512-516.
4. Riethdorf S., Wikman H., Pantel K. Review: biological relevance of disseminated tumor cells in cancer patients. Int J Cancer 2008, 123:1991-2006.
5. Maheswaran S., Haber D.A. Circulating tumor cells: a window into cancer biology and metastasis. Curr Opin Genet Dev 2010, 20:96-99.
6. Mitchell M.J., King M.R. Fluid shear stress sensitizes cancer cells to receptor-mediated apoptosis via trimeric death receptors. New J Phys 2013, 15:015008.
7. Mitchell M.J., King M.R. Computational and experimental models of cancer cell response to fluid shear stress. Front Oncol 2013, 3:1-11.
8. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420:860-867.
9. Lawrence M.B., Springer T.A. Neutrophils roll on E-selectin. JImmunol 1993, 151:6339-6346.
10. McDonald B., Spicer J., Giannais B., Fallavollita L., Brodt P., Ferri L. Systemic inflammation increases cancer cell adhesion to hepatic sinusoids by neutrophil mediated mechanisms. Int J Cancer 2009, 125:1298-1305.
11. van Ginhoven T.M., van den Berg J.W., Dik W.A., Ijzermans J.N.M., de Bruin R.W.F. Preoperative dietary restriction reduces hepatic tumor load by reduced E-selectin-mediated adhesion in mice. JSurg Oncol 2010, 102:348-353.
12. Gassmann P., Kang M.L., Mees S.T., Haier J. Invivo tumor cell adhesion in the pulmonary microvasculature is exclusively mediated by tumor cell-endothelial cell interaction. BMC Cancer 2010, 10:177.
13. Yin X., Rana K., Ponmudi V., King M.R. Knockdown of fucosyltransferase III disrupts the adhesion of circulating cancer cells to E-selectin without affecting hematopoietic cell adhesion. Carbohydr Res 2010, 345:2334-2342.
14. Rahn J.J., Chow J.W., Horne G.J., Mah B.K., Emerman J.T., Hoffman P., et al. MUC1 mediates transendothelial migration invitro by ligating endothelial cell ICAM-1. Clin Exp Metastasis 2005, 22:475-483.
15. Mitchell M.J., Wayne E., Rana K., Schaffer C.B., King M.R. TRAIL-coated leukocytes that kill cancer cells in the circulation. Proc Natl Acad Sci U S A 2014, 111:930-935.
16. Mitchell M.J., King M.R. Leukocytes as carriers for targeted cancer drug delivery. Expert Opin Drug Deliv 2014, 1-18.
17. Mitchell M.J., Castellanos C.A., King M.R. Nanostructured surfaces to target and kill circulating tumor cells while repelling leukocytes. JNanomater 2012, 2012:1-10.
18. Mitchell M.J., King M.R. Unnatural killer cells to prevent bloodborne metastasis: inspiration from biology and engineering. Expert Rev Anticancer Ther 2014, 14:641-644.
19. Hughes A.D., Marshall J.R., Keller E., Powderly J.D., Greene B.T., King M.R. Differential drug responses of circulating tumor cells within patient blood. Cancer Lett 2013, 352(1):28-35.
20. Luo X., Mitra D., Sullivan R.J., Wittner B.S., Kimura A.M., Pan S., et al. Isolation and molecular characterization of circulating melanoma cells. Cell Rep 2014, 645-653.
21. Greene B.T., Hughes A.D., King M.R. Circulating tumor cells: the substrate of personalized medicine?. Front Oncol 2012, 2:1-6.
22. Allard W.J., Matera J., Miller M.C., Repollet M., Connelly M.C., Rao C., et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 2004, 10:6897-6904.
23. Yu M., Stott S., Toner M., Maheswaran S., Haber D.A. Circulating tumor cells: approaches to isolation and characterization. JCell Biol 2011, 192:373-382.
24. Miller M.C., Doyle G.V., Terstappen L.W.M.M. Significance of circulating tumor cells detected by the CellSearch system in patients with metastatic breast colorectal and prostate cancer. JOncol 2010, 2010:617421.
25. Nagrath S., Sequist L.V., Maheswaran S., Bell D.W., Irimia D., Ulkus L., et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 2007, 450:1235-1239.
26. Hughes A.D., Mattison J., Western L.T., Powderly J.D., Greene B.T., King M.R. Microtube device for selectin-mediated capture of viable circulating tumor cells from blood. Clin Chem 2012, 58:846-853.
27. Bajpai S., Mitchell M.J., King M.R., Reinhart-King C.A. Amicrofluidic device to select for cells based on chemotactic phenotype. Technology 2014, 02:101-105.
28. Mitchell M.J., Chen C.S., Ponmudi V., Hughes A.D., King M.R. E-selectin liposomal and nanotube-targeted delivery of doxorubicin to circulating tumor cells. JControl Release 2012, 160:609-617.
29. Liu M., Guo B., Du M., Cai X., Jia D. Properties of halloysite nanotube-epoxy resin hybrids and the interfacial reactions in the systems. Nanotechnology 2007, 18:455703.
30. Abdullayev E., Joshi A., Wei W., Zhao Y., Lvov Y. Enlargement of halloysite clay nanotube lumen by selective etching of aluminum oxide. ACS Nano 2012, 6:7216-7226.
31. Lvov Y.M., Shchukin D.G., Möhwald H., Price R.R. Halloysite clay nanotubes for controlled release of protective agents. ACS Nano 2008, 2:814-820.
32. Veerabadran N.G., Price R.R., Lvov Y.M. Clay nanotubes for encapsulation and sustained release of drugs. Nano 2007, 02:115-120.
33. Cavallaro G., Lazzara G., Milioto S. Exploiting the colloidal stability and solubilization ability of clay nanotubes/ionic surfactant hybrid nanomaterials. JPhys Chem C 2012, 116:21932-21938.
34. Hughes A.D., King M.R. Use of naturally occurring halloysite nanotubes for enhanced capture of flowing cells. Langmuir 2010, 26:12155-12164.
35. Mitchell M.J., King M.R. Shear-induced resistance to neutrophil activation via the formyl peptide receptor. Biophys J 2012, 102:1804-1814.
36. Mitchell M.J., Lin K.S., King M.R. Fluid shear stress increases neutrophil activation via platelet-activating factor. Biophys J 2014, 106:2243-2253.
37. Horcas I., Fernández R., Gómez-Rodríguez J.M., Colchero J., Gómez-Herrero J., Baro A.M. WSXM: a software for scanning probe microscopy and a tool for nanotechnology. Rev Sci Instrum 2007, 78:013705.
38. Silberberg M.S. Chemistry: the molecular nature of matter and change 2008, McGraw Hill. 5th ed.
39. Chen W., Weng S., Zhang F., Allen S., Li X., Bao L., et al. Nanoroughened surfaces for efficient capture of circulating tumor cells without using capture antibodies. ACS Nano 2013, 7:566-575.
40. Ball C., King M. Role of c-Abl in L-selectin shedding from the neutrophil surface. Blood Cells Mol Dis 2011, 46:246-251.
41. Cao T.M., Mitchell M.J., Liesveld J., King M.R. Stem cell enrichment with selectin receptors: mimicking the ph environment of trauma. Sensors 2013, 13:12516-12526.
42. Kim M.B., Sarelius I.H. Distributions of wall shear stress in venular convergences of mouse cremaster muscle. Microcirculation 2003, 10:167-178.
43. Myung J.H., Gajjar K.A., Pearson R.M., Launiere C.A., Eddington D.T., Hong S. Direct measurements on CD24-mediated rolling of human breast cancer MCF-7 cells on E-selectin. Anal Chem 2011, 83:1078-1083.
44. Shafie S.M., Liotta L.A. Formation of metastasis by human breast carcinoma cells (MCF-7) in nude mice. Cancer Lett 1980, 11:81-87.
45. Mattila M.M.-T., Ruohola J.K., Karpanen T., Jackson D.G., Alitalo K., Härkönen P.L. VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors. Int J Cancer 2002, 98:946-951.
46. Kawada K., Hosogi H., Sonoshita M., Sakashita H., Manabe T., Shimahara Y., et al. Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes. Oncogene 2007, 26:4679-4688.
47. Tate C.R., Rhodes L.V., Segar H.C., Driver J.L. Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat. Breast Cancer Res 2012, 14:R79.
48. Julien S., Ivetić A., Grigoriadis A., QiZe D., Burford B., Sproviero D., et al. Selectin ligand sialyl-Lewis x antigen drives metastasis of hormone-dependent breast cancers. Cancer Res 2011, 71:7683-7693.
49. Evani S.J., Prabhu R.G., Gnanaruban V., Finol E.A., Ramasubramanian A.K. Monocytes mediate metastatic breast tumor cell adhesion to endothelium under flow. FASEB J 2013, 27:3017-3029.
50. Vorobyov I., Bekker B., Allen T.W. Electrostatics of deformable lipid membranes. Biophys J 2010, 98:2904-2913.
51. Parodi A., Quattrocchi N., van de Ven A.L., Chiappini C., Evangelopoulos M., Martinez J.O., et al. Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. Nat Nanotechnol 2012, 8:61-68.
52. Zhang Y., Yang M., Park J.-H., Singelyn J., Ma H., Sailor M.J., et al. Asurface-charge study on cellular-uptake behavior of F3-peptide-conjugated iron oxide nanoparticles. Small 2009, 5:1990-1996.
53. Zhang Y., Yang M., Portney N.G., Cui D., Budak G., Ozbay E., et al. Zeta potential: a surface electrical characteristic to probe the interaction of nanoparticles with normal and cancer human breast epithelial cells. Biomed Microdevices 2008, 10:321-328.
54. Mitchell M.J., King M.R. Theme: physical biology in cancer. 3. The role of cell glycocalyx in vascular transport of circulating tumor cells. AJP Cell Physiol 2014, 306:C89-C97.
55. Hopwood J.J., Dorfman A. Glycosaminoglycan synthesis by cultured human skin fibroblasts after transformation with simian virus 40. JBiol Chem 1977, 252:4777-4785.
56. Itano N., Kimata K. Altered hyaluronan biosynthesis in cancer progression. Semin Cancer Biol 2008, 18:268-274.